Company Research
Whether you are exploring new sales opportunities or researching a new investment, FirstRain provides unique insight into important developments for Boston Scientific Corporation (BSX). You can receive reports or configure the research engine for yourself.
Report On:
Boston Scientific Corporation (BSX)
HEALTHCARE - Health Services - Medical Instruments & Supplies
Generated: Thursday September 15, 2011 04:06 AM
|
|
||||||||||||||||||
Quotes About Boston Scientific Corporation
-
BSX CEO Elliott: Med-tech tax "an outrage"
It's an outrage. It is soaking one of the last remaining industries in this country that pays 50 percent more per average income than the rest of industry. We're the last remaining, as far as I know, major private segment that is trade-positive,"
- Ray Elliott -
Boston Scientific CFO: We'll use cash to buy back shares, make acquisitions
We're to a point where really the only significant obligations we have in a debt capacity aren't maturing until 2014, so the company is in a great position from a capital perspective,"
- Jeffrey Cappello -
Johnson & Johnson mulls heart device biz
Both [technologies] are interesting. We are interested in looking at them,"
- Dominic Caruso -
Boston Scientific Gets New Boss, Eventually (BSX, JNJ, ABT)
transition period is being implemented to accommodate Mahoney's post-employment obligations to Johnson & Johnson, which both Boston Scientific and Johnson & Johnson have agreed is appropriate." -
J&J Veteran to Lead Boston Scientific
I was pleasantly surprised by the hire,"
- Jan Wald
No Comment
-
For J&J and Boston Scientific, a Curious CEO Pick Marks a Ceasefire
Of course J&J, which declined to comment on the speculation, is in the process of closing on a $21.3 billion acquisition of another device company, Synthes .
- Larry Biegelsen
-
J&J Veteran to Lead Boston Scientific
A Boston Scientific spokesman said Mahoney was not available for interviews on Tuesday because he is not an employee yet.
- Jan Wald
-
CEO Transitions at Boston-Power and Boston Scientific: Schmid Out at Battery Firm, Mahoney In at BSX
A spokesperson for Boston-Power declined to offer any comment beyond what has been reported in area media outlets today; the accuracy of the reports was not disputed, however.
- Christina-Lampe Onnerud
Latest Company Intelligence
-
Correction: Boston Scientific-Personnel
El Paso Times | Sep 14,'11
NEW YORK—In a story about Boston Scientific Corp.'s incoming CEO, the Associated Press erroneously reported the date when William Kucheman will become interim CEO. Kucheman will become interim CEO on Oct. 17. -
For J&J and Boston Scientific, a Curious CEO Pick Marks a Ceasefire
Health Blog - The Wall Street Journal | Sep 14,'11
We confess our eyebrows went up here at Health Blog headquarters when news crossed the wires late yesterday that Johnson & Johnson's top medical-device exec Michael Mahoney was named president and will eventually be CEO at beleaguered Boston Scientific . The word “rivalry” is hardly sufficient to describe the bare-knuckled hostility that has characterized relations between the two -
Close [X] Quick links to the best of SFGate | Still can't find it? see Site Index News » Today Breaking News Live Views Traffic Weather Sections Bay Area & State Business Chronicle Magazine Crime Education Green Health & Medicine Home Guides...
SFGate | Sep 14,'11
Boston Scientific Corp.'s choice of Johnson & Johnson executive Michael Mahoney to become its next leader drew praise from analysts covering the medical device maker. The Natick, Mass., company said after the markets closed Tuesday that Mahoney, 46, will become president on Oct. 17 and is expected to become CEO in November 2012. Current CEO Ray Elliott will step down on Oct. 17 as -
Boston Scientific Gets New Boss, Eventually (BSX, JNJ, ABT)
24/7 Wall St | Sep 14,'11
Medical device maker Boston Scientific Corp. (NYSE: BSX) has named a new president who will take over on October 17th and who will then be elevated to CEO on November 1, 2012. Was Boston Scientific's board dozing when it agreed to this? The lucky guy is Michael Mahoney, who is currently Worldwide Chairman of the Medical Device and Diagnostics group at Johnson & Johnson (NYSE: JNJ). -
Boston Scientific turns to rival for new CEO
The BBJ's Morning Roundup - Bizjournals | Sep 14,'11
Boston Scientific (NYSE: BSX) has tapped Johnson & Johnson executive Michael Mahoney as its new CEO. Chief executive Ray Elliott announced his pending retirement in May. Boston Scientific Corp. Boston Scientific Corp. Latest from The Business Journals Boston Sci picks J&J exec for new CEO Boston Scientific picks J&J executive as next CEO Stents don't stop strokes in study Follow this -
CEO Transitions at Boston-Power and Boston Scientific: Schmid Out at Battery Firm, Mahoney In at BSX
Xconomy | Sep 13,'11
Interesting day for a couple of companies whose names start with “Boston.” Who's next, Boston Dynamics? Boston Harbor Cruises? Maybe the Boston Red Sox. —Westborough, MA-based Boston-Power, a developer of advanced lithium-ion battery technology, saw three top executives leave last Friday, including CEO Keith Schmid. The news was first reported by Mass High Tech this morning. ▪
FirstRain customers use intelligent business search to find actionable insights about companies, management, and industries. You can review company briefs, quickly research a new idea or opportunity, generate personalized industry reports, or set up alerts on reasons to call. Be sure to view our sample reports below.
